Alkem develops anti-diabetic, anti-malarial, cardiovascular, immunosuppressants, nutraceuticals and pain management products... Read more
Alkem develops anti-diabetic, anti-malarial, cardiovascular, immunosuppressants, nutraceuticals and pain management products... Read more
News
Acquisition
Feb 10, 2025
The Economic Times
Alkem Laboratories Ltd acquired Adroit Biomed Ltd for $16M
Product Launch
Feb 05, 2025
Indian Pharma Post
Alkem launches Kojiglo serum to manage facial hyperpigmentation
investment
Jun 05, 2024
https://www.business-standard.com/markets/capital-market-news/alkem-laboratories-to-invest-rs-30-cr-in-haystackanalytics-124060600846_1.html
Alkem Laboratories Ltd has invested $4M in HaystackAnalytics Private Limited
